Sana Biotechnology’s first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes without immunosuppression.
Sana Biotechnology Stock Surges Over 200% On Wednesday – Here’s Why
Where Today's News Shapes Tomorrow
